- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04934280
Diagnostic Yield of Transvaginal Ultrasonography Versus Sonohysterography in Detection of Ceserean Section Niche
June 19, 2021 updated by: Radwa Ahmed Elbahy Mohamed, Sohag University
Diagnostic Yield of Transvaginal Ultrasonography Versus Sonohysterography in the Evaluation of Ceserean Section Niche.
The aim of this study is to compare the identification of CS scar niche between 2D transvaginal ultrasonography alone and with the use of saline infusion as a contrast.
Does it differ in the measurements and identification or not.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Cesarean section (CS) rate is increasing in recent practice with a corresponding increase in associated complication.
One of these complications is the CS scar defect or 'niche'.
A niche forms after CS at the site of hysterotomy of the anterior uterine wall.
Recently, it has been demonstrated that niche may be the causative factor for abnormal uterine bleeding, dysmenorrhea, obstetric complications in subsequent pregnancies and possibly subfertility.
Therefore, the accurate measurement and description of a niche is becoming increasingly important, for the clinical assessment of gynecological symptoms and for the planning of possible surgical treatment.A niche can be examined using two- (2D) or three- (3D) dimensional transvaginal sonography (TVS), with or without saline or gel contrast, magnetic resonance imaging and hysteroscopy.
We will examine about 30 patients of non pregnant women with previous CS having gynecological complications or seeking fertility.
All participants will be subjected to 2D vaginal examination to exclude uterine pathology followed by 2D transvaginal ultrasonography with saline infusion using 10-20 ml of sterile Na Cl 0.9% solution injected through the cervix using a 2 mm sterile disposable catheter or IOL Foley catheter.
The procedure will be done postmenstrually.
Study Type
Interventional
Enrollment (Anticipated)
2
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- women with previous CS section scar seeking pregnancy or having gynecological complications
Exclusion Criteria:
- women having other gynecological pathology other than niche
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: 2D transvaginal ultrasonography
|
saline infusion transvaginally followed by 2D transvaginal ultrasound imaging
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
accurate evaluation of CS section niche
Time Frame: 6 months from the date of approval
|
comparison of imaging CS niche by 2D transvaginal US and sonohysterography
|
6 months from the date of approval
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
June 20, 2021
Primary Completion (Anticipated)
December 20, 2021
Study Completion (Anticipated)
February 20, 2022
Study Registration Dates
First Submitted
June 16, 2021
First Submitted That Met QC Criteria
June 19, 2021
First Posted (Actual)
June 22, 2021
Study Record Updates
Last Update Posted (Actual)
June 22, 2021
Last Update Submitted That Met QC Criteria
June 19, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- Soh-Med-21-06-10
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section Niche Evaluation
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Ain Shams UniversityCompletedCesarean Section; Dehiscence | Cesarean Scar NicheEgypt
-
Zagazig UniversityRecruitingCesarean Section Niche Impact on ARTEgypt
-
Tanta UniversityCompletedCesarean Section; Dehiscence | Cesarean Wound; Dehiscence | Cesarean Scar NicheEgypt
-
Ospedale Policlinico San MartinoCompletedCesarean Section Complications | Uterine Niche | Isthmocele | Uterine Scar DefectsItaly
-
University of AarhusRanders Regional HospitalActive, not recruitingCesarean Scar NicheDenmark
-
Zagazig UniversityRecruitingCesarean Scar NicheEgypt
-
Mahmoud Ramadan HafezRecruitingCesarean Section Niche and Abnormal Uterine BleedingEgypt
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Ataturk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
Clinical Trials on sonohysterography
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); American College of Obstetricians and GynecologistsCompletedEndometrial CancerUnited States
-
Ain Shams UniversityUnknown
-
University of Wisconsin, MadisonCompleted
-
Aljazeera HospitalCompleted
-
Royan InstituteCompleted
-
Woman's Health University Hospital, EgyptUnknownGynecologic DiseaseEgypt
-
Ludwin & Ludwin Gynecology, Private Medical CenterJagiellonian University; University of Sao PauloCompletedInfertility, | Abortions, Spontaneous, HabitualPoland
-
Cook Group IncorporatedTerminatedUterine Neoplasms | Polycystic Ovary Syndrome | Endometrial Neoplasms | MenorrhagiaPanama
-
Cairo UniversityCompleted